洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2100048749】Implementation and evaluation of an evidence-based intervention protocol for the prevention of hypothermia of the preterm infants in the delivery room and after admission to the NICU

基本信息
登记号

ChiCTR2100048749

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-07-15

临床申请受理号

/

靶点

/

适应症

Premature baby

试验通俗题目

Implementation and evaluation of an evidence-based intervention protocol for the prevention of hypothermia of the preterm infants in the delivery room and after admission to the NICU

试验专业题目

Implementation and evaluation of an evidence-based intervention protocol for the prevention of hypothermia of the preterm infants in the delivery room and after admission to the NICU

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

(1) develop and implement an evidence-based clinical practice guideline on prevention of hypothermia of the preterm infants in the delivery room and after admission to the NICU; (2) evaluate the effectiveness of the guideline on prevention of hypothermia of the preterm infants in the delivery room and after admission to the NICU

试验分类
试验类型

非随机对照试验

试验分期

其它

随机化

No

盲法

N/A

试验项目经费来源

N/A

试验范围

/

目标入组人数

60

实际入组人数

/

第一例入组时间

2021-07-31

试验终止时间

2022-06-30

是否属于一致性

/

入选标准

All infants born before 32 weeks of gestation;

排除标准

(1) presence of congenital anomalies with open lesions (e.g. gastroschisis and meningomyelocele) and babies whose deliveries were not attended by the neonatal team; (2) infants with life-threatening congenital anomalies identified antenatally or at birth.;

研究者信息
研究负责人姓名
试验机构

香港中文大學威爾士親王醫院

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品